Notable Wednesday optional activity: HZNP, AYX, GKOS

AAmong the underlying constituents of the Russell 3000 Index, we saw remarkable options trading volume today at Horizon Therapeutics plc (ticker: HZNP), where a total of 9,030 contracts were traded up to present, representing approximately 903,000 underlying shares. This equates to approximately 52.1% of HZNP’s average daily trading volume over the past month of 1.7 million shares. Particularly high volume was seen for the $95 strike put option expiring on May 20, 2022, with 2,979 contracts traded so far today, representing approximately 297,900 underlying shares of HZNP. Below is a chart showing HZNP’s trading history over the past twelve months, with the $95 strike highlighted in orange:

Alteryx Inc (Symbol: AYX) recorded options trading volume of 3,488 contracts, representing approximately 348,800 underlying stocks or approximately 52% of AYX’s average daily trading volume over the past month of 670 415 shares. Particularly high volume was seen for the $85 strike call option expiring May 20, 2022, with 773 contracts traded so far today, representing approximately 77,300 underlying AYX shares. Below is a chart showing AYX’s trading history over the last twelve months, with the $85 strike highlighted in orange:

And Glaukos Corp (ticker: GKOS) options have a volume of 2,880 contracts to date. This number of contracts represents approximately 288,000 underlying shares, or 50.8% of GKOS’ average daily trading volume over the past month, or 567,215 shares. Particularly high volume was seen for the $47.50 strike put option expiring May 20, 2022, with 1,093 contracts traded so far today, representing approximately 109,300 underlying GKOS shares. . Below is a chart showing GKOS’ past twelve month trading history, with the $47.50 strike highlighted in orange:

For the different expirations available for HZNP options, AYX options or GKOS options, visit StockOptionsChannel.com.

Most active call and put options on the S&P 500 today »

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.